“…The binding of n -heptane and di- n -butyl ether with [C 12 ] 3 [PW 12 O 40 ] NPs is expected to reduce the [C 18 /SO 3 H]@SiO 2 /[C 12 ] 3 [PW 12 O 40 ] interaction. The results indicate that the most hydrophobic solvent ( n -heptane) provides a stronger inhibitory effect due to easier penetration into the [C 12 ] 3 [PW 12 O 40 ] NPs in agreement with the eluotropic series 29. To gain more insight into the attractive interactions between the NPs, an experiment was performed for the [C 8 /SO 3 H]@SiO 2 /[C 12 ] 3 [PW 12 O 40 ] system (entry 10).…”
“…The binding of n -heptane and di- n -butyl ether with [C 12 ] 3 [PW 12 O 40 ] NPs is expected to reduce the [C 18 /SO 3 H]@SiO 2 /[C 12 ] 3 [PW 12 O 40 ] interaction. The results indicate that the most hydrophobic solvent ( n -heptane) provides a stronger inhibitory effect due to easier penetration into the [C 12 ] 3 [PW 12 O 40 ] NPs in agreement with the eluotropic series 29. To gain more insight into the attractive interactions between the NPs, an experiment was performed for the [C 8 /SO 3 H]@SiO 2 /[C 12 ] 3 [PW 12 O 40 ] system (entry 10).…”
“…Because both MLN0128 and STK040263 are amine derivatives, they have tendency to adsorb on the silica solid support. The use of ammonium formate (10.0 m m at pH 2.8) as a component of the mobile phase not only promotes the formation of protonated analytes, but also dynamically competes with the analyte and the IS to prevent chemical tailing on the column (Hansen, Helboa, & Lund, ; McDowall, Pearce, & Murkitt, ). Furthermore, for achieving a proper solvent strength and selectivity, a mixture of methanol and acetonitrile at a ratio of 85:15 ( v /v) was used as another component of the mobile phase for rapid and efficient separation of the analyte and the IS.…”
Section: Resultsmentioning
confidence: 99%
“…As shown in Figure 1 The mass spectra of precursor and product ions of MLN0128 and STK040263. Experimental conditions were the same as those described in the section 'Tandem mass spectrometry' chemical tailing on the column (Hansen, Helboa, & Lund, 1984;McDowall, Pearce, & Murkitt, 1989…”
MLN0128, an mTOR kinase inhibitor, is currently undergoing clinical investigation for treatment of a variety of cancers. To support this work, an LC-MS/MS method has been developed for the determination of MLN0128 in human plasma. A structural analog STK040263 was used as the internal standard. Both MLN0128 and the IS were first extracted from plasma using methyl tert-butyl ether; then separated on a Waters XTerra® MS C column using a mobile phase consisting of methanol-acetonitrile-10.0 mm ammonium formate (34:6:60, v/v/v) at a flow rate of 0.300 mL min . Quantitation of MLN0128 was done by positive electrospray ionization tandem mass spectrometry in multiple-reaction-monitoring mode. This method has a total run time of <4 min with the retention times of 1.95 and 2.94 min for the IS and MLN0128, respectively. The method has been validated per the US Food and Drug Administration guidance for bioanalytical method validation. It has a calibration range of 0.100-50.0 ng mL in human plasma with a correlation coefficient > 0.999. The overall assay accuracy and precision were ≤ ± 4 and ≤8%, respectively. The IS normalized recovery of MLN0128 was 98-100%. The stability studies showed that MLN0128 was stable under all tested conditions. The method developed may be useful for clinical studies of MLN0128.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.